Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-10-05FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves Macleods Pharmaceuticals Limited's venlafaxine hydrochloride original application (generic), expanding access to treatment for …
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD) [NA]
A completed clinical trial evaluated telephone psychotherapy for late-life generalized anxiety disorder, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Levetiracetam for the Treatment of Alcohol Dependence and Anxiety [Phase 2]
Phase 2 trial update for levetiracetam in treating alcohol dependence and anxiety disorders; results completed with posted results in 2017.
-
FDA approval · 2017-08-18FDA Approved: PAROXETINE — Original Application (Solco Healthcare LLC)
FDA approves the original generic application for Paroxetine (Solco Healthcare LLC).
-
CLINICAL_TRIALS withdrawal · 2017-08-17Clinical Trial Update: Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men [Phase 1, Phase 2]
A Phase 1/2 clinical trial of a mobile phone app for depressive symptoms and generalized anxiety in young men who have sex with men was with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Effectiveness Study of CBT for Anxiety in Children [Phase 2]
Phase 2 study evaluating the effectiveness of cognitive-behavioral therapy for anxiety in children. The study included participants with sep…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Pharmacogenetics in Primary Care Psychotropics [Phase 3]
Phase 3 clinical trial update on pharmacogenetics in primary care psychotropics sponsored by the University of Arizona, studying major depre…
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD) [NA]
A completed clinical trial from Emory University evaluating the efficacy of massage therapy for generalized anxiety disorder.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Cognitive Training for Mood and Anxiety Disorders [NA]
Completed clinical trial evaluating cognitive training for mood and anxiety disorders, sponsored by Icahn School of Medicine at Mount Sinai.
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Long Term Chamomile Therapy for Anxiety [Phase 3]
Phase 3 trial evaluating long-term chamomile therapy for generalized anxiety disorder has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Training Protocol 'Drop it'. The Impact of a Training Protocol Focused on Coping With Negative Repetitive Thinking on Cognitive and Behavioural Functioning of People Suffering From GAD or Minor or Moderate Depressive Disorder or Depressive Disorder in Remission [NA]
This clinical trial update reports the completion of a study evaluating a training protocol to cope with negative repetitive thinking in peo…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Primary Care Intervention Strategy for Anxiety Disorders [Phase 4]
Phase 4 trial update reporting results of a primary care intervention strategy for anxiety disorders, including PTSD and generalized anxiety…
-
FDA approval · 2017-05-18FDA Approved: DULOXETINE — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original application for duloxetine, enabling the marketing of a generic duloxetine product.
-
FDA approval · 2017-05-17FDA Approved: ESCITALOPRAM OXALATE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' original application for escitalopram oxalate, a generic version of escitalopram used to treat major de…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Generalized Anxiety and Seroquel [NA]
Terminated clinical trial evaluating Seroquel XR for generalized anxiety disorder; results were posted in May 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Drug Therapy for Generalized Anxiety Disorder Among the Elderly [Phase 4]
Phase 4 trial results update for a drug therapy targeting generalized anxiety disorder in elderly patients, with results posted in 2017.
-
FDA approval · 2017-04-28FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA has approved a supplemental application for paroxetine filed by Padagis US LLC. This notice indicates FDA approval of an amendment t…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Child and Adolescent Anxiety Disorders (CAMS) [Phase 3]
A Phase 3 clinical trial update for Child and Adolescent Anxiety Disorders (CAMS) has completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder [NA]
A terminated clinical trial evaluated transcranial magnetic stimulation for generalized anxiety disorder, with results posted on 2017-04-10.
-
FDA approval · 2017-04-06FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for duloxetine submitted by Zydus Lifesciences Limited, advancing the regulatory status of the g…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: CBT for GAD: Impact of Cognitive Processing on Treatment Outcome [NA]
A clinical trial conducted by Concordia University, Montreal has completed a study evaluating how cognitive processing influences treatment …
-
FDA approval · 2017-03-31FDA Approved: ALPRAZOLAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Alprazolam from Hikma Pharmaceuticals USA Inc., authorizing sale of a generic alprazolam pro…
-
FDA approval · 2017-03-24FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved a generic venlafaxine hydrochloride product from Westminster Pharmaceuticals, LLC under an Original Application. This approval …
-
FDA approval · 2017-03-23FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for duloxetine hydrochloride from Macleods Pharmaceuticals Limited, authorizing a generic version of d…
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Combined Treatment for Generalized Anxiety Disorder (GAD) [Phase 2]
Phase 2 clinical trial evaluating a combined treatment for generalized anxiety disorder has completed. The results were posted in February 2…